Investment Summary
Recommendation
HOLD
Downgraded from BUY
Target Price (12m)
Rs 550–600
-5% to +4% from current
Current P/E (Trailing)
11.67x
Above 5-yr avg (10.5x)
Current P/B
3.73x
Significant premium to book
Dividend Yield
4.84%
Moderate income component
ROE
33.84%
Industry-leading
Capital Adequacy
19.20%
Well above 11.5% minimum
Forward P/E (Annualized H1'26)
10.65x
In line with 5-yr average
Thesis: Meezan Bank's fundamental strength remains intact (industry-leading ROE, fortress balance sheet, recovering earnings), but the stock price surge to Rs 578.15 has priced in much of the near-term recovery expectation. Valuation metrics now exceed historical averages, suggesting limited near-term upside. Maintain HOLD rating; await further earnings confirmation or a price correction for better entry.
Key Price-Dependent Metrics Update
All financials unchanged from annual report; only market-driven metrics updated for current price of Rs 578.15.
| Metric | Year-End 2025 | Today (Rs 578.15) | Change |
|---|---|---|---|
| Stock Price | Rs 444.38 | Rs 578.15 | ▲ 29.9% |
| Market Cap | Rs 800.13B | Rs 1,040.84B | ▲ 30.1% |
| P/B Ratio | 2.87x | 3.73x | ▲ 0.86x |
| P/E Ratio (Trailing) | 8.97x | 11.67x | ▲ 2.70x |
| Dividend Yield | ~6.30% | ~4.84% | ▼ 1.46pp |
| EPS 2025 | Rs 49.54 | Rs 49.54 | — |
| BVPS | Rs 155.10 | Rs 155.10 | — |
Forward Valuation (using H1'26 annualized earnings):
• H1'26 PAT: Rs 48.90B → Annualized PAT: ~Rs 97.80B
• Annualized EPS: ~Rs 54.30
• Forward P/E: 578.15 / 54.30 ≈ 10.65x (in line with 5-year avg)
• H1'26 PAT: Rs 48.90B → Annualized PAT: ~Rs 97.80B
• Annualized EPS: ~Rs 54.30
• Forward P/E: 578.15 / 54.30 ≈ 10.65x (in line with 5-year avg)
Valuation Analysis
Relative Valuation vs. History
| Metric | Current | 5-Year Avg | Verdict |
|---|---|---|---|
| P/E (Trailing) | 11.67x | ~10.5x | Slightly expensive |
| P/B | 3.73x | ~2.0x | Premium justified? |
| Dividend Yield | 4.84% | ~5.0% | Below average |
| ROE | 33.8% | ~38.0% | Below peak but strong |
ROE Justification Check
Meezan's ROE (33.8%) significantly exceeds Islamic banking peers (~25-30%). Sustainable ROE range: 30-35% (based on 6-year trend & CASA-driven efficiency).
Implied Fair P/B Range: 2.5–3.2x (using P/B ≈ ROE / Cost of Equity; Ke ≈ 12.5%)
Current P/B (3.73x) suggests market pricing in ROE expansion to ~38-40%.
Forward Earnings Perspective
Conservative Case
P/E 11.67x
Overvalued vs. history
Base Case
P/E 10.65x
Fairly valued
Bull Case
P/E < 10.3x
Undervalued
Conclusion: Current price assumes modest earnings recovery. Further upside depends on: (1) Confirmation of H1'26 momentum in H2'26, (2) Sustained CASA growth (>20% YoY) lowering funding costs, (3) Continued SCF/digital expansion boosting fee income.
Investment Recommendation
Recommendation: HOLD
(Downgraded from BUY in original report)
Rationale
✅ Strengths Unchanged
- Industry-best asset quality (NPL 1.86%, coverage 146%)
- Fortress balance sheet (CAR 19.20%, CASA 91% of deposits)
- Proven earnings resilience (PAT 4x growth 2020-2025 despite rate cycles)
- Leadership transition executed smoothly (H1'26 PAT up 6% YoY)
- Dividend sustainability (payout ratio ~50% of earnings)
⚠️ Valuation Concerns
- Stock has rallied ~30% since Dec 2025, outpacing earnings growth
- Trailing P/E (11.67x) now exceeds 5-year average (10.5x)
- P/B premium (3.73x vs. historical 2.0x) requires ROE expansion to justify
- Limited near-term upside unless earnings accelerate beyond expectations
Target Price Range: Rs 550–600
| Scenario | Target Price | Key Assumptions |
|---|---|---|
| Bull Case | Rs 600 | 2026 EPS ≥ Rs 55.00 (P/E 10.9x) + P/B expansion to 3.85x |
| Base Case | Rs 575 | Matches current price; assumes 2026 EPS ~Rs 52.50 (P/E 10.95x) |
| Bear Case | Rs 550 | P/E compression to 10.5x if earnings disappoint |
Actionable Guidance
- Hold current positions; strong fundamentals support price
- Consider adding only on dips below Rs 550 (10.5x P/E)
- Review if H2'26 earnings show >15% YoY growth or ROE sustains >35%
Unchanged Fundamentals (From Audited 2025 & Unaudited H1'26)
All business model, financial performance, risk factors, and strategic initiatives remain identical to the original analysis since they are based on disclosed financial statements—not short-term price movements.
Financial Strength (2025 Audited)
Profit After Tax
Rs 89.04B
▼ 12% YoY
Total Deposits
Rs 3.30T
▲ 28% YoY
Total Assets
Rs 4.81T
▲ 23% YoY
NPL Ratio
1.86%
Industry-low
Capital Adequacy
19.20%
Min: 11.5%
CASA Ratio
91%
Low-cost funding
Strategic Progress (2025)
Digital Accounts
460k+
New in 2025
Mobile Users
4.36M
▲ from 3.1M
SCF Portfolio
Rs 12.3B
▲ 70% YoY
Solar Branches
196
4.3 MW capacity
Branch Network
1,105
+54 branches
Trees Planted
10,000
CO₂ offset: 1,320 tons
Half-Year 2026 (Unaudited) – Recovery Signs
| Metric | H1'26 | H1'25 | Change |
|---|---|---|---|
| Profit After Tax | Rs 48.90B | Rs 46.16B | ▲ 6.0% |
| Basic EPS | Rs 27.15 | Rs 25.72 | ▲ 5.6% |
| ROE | 34.7% | — | Improvement |
| ROA | 2.0% | — | Stable |
| Total Assets | Rs 5.14T | Rs 4.81T (Dec'25) | ▲ 7.0% |
| Deposits | Rs 3.74T | Rs 3.30T (Dec'25) | ▲ 13.4% |
| CASA Ratio | 91% | 91% | Stable |
| ADR (Gross) | 43.8% | 51.1% (Dec'25) | Lower |
Key Risks & Mitigants
| Risk | Mitigation / Reality Check |
|---|---|
| Further Policy Rate Cuts | Rate cycle likely bottomed (SBP raised rate 100bps in Apr'26). Asset-sensitive balance sheet: 50%+ floating rate assets. CASA focus reduces funding cost sensitivity. |
| Asset Quality Deterioration | NPL ratio industry-low (1.86%). Conservative provisioning (coverage 146%). Corporate book diversified; strong SME/SCF growth (low-risk). |
| Leadership Transition Execution Risk | New CEO is ex-Meezan with Islamic banking expertise. Board continuity; clear succession plan. Early results (H1'26) show stability. |
| Digital Transformation Delays | 460k+ new digital accounts in 2025. Successful app migration completed. ATM/branch biometrics deployed; IBFT/UBPS growing 54% YoY. |
| Concentration in Govt Securities | GoP Ijarah Sukuk are zero-risk (sovereign). Provides liquidity buffer for financing growth. Yield >6% attractive vs. alternatives. |